Cargando…
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies
Regenerative medicine relying on cell and gene therapies is one of the most promising approaches to repair tissues. Multipotent mesenchymal stem/stromal cells (MSC), a population of progenitors committing into mesoderm lineages, are progressively demonstrating therapeutic capabilities far beyond the...
Autores principales: | D’souza, Naomi, Rossignoli, Filippo, Golinelli, Giulia, Grisendi, Giulia, Spano, Carlotta, Candini, Olivia, Osturu, Satoru, Catani, Fabio, Paolucci, Paolo, Horwitz, Edwin M., Dominici, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534031/ https://www.ncbi.nlm.nih.gov/pubmed/26265166 http://dx.doi.org/10.1186/s12916-015-0426-0 |
Ejemplares similares
-
A 3D Platform to Investigate Dynamic Cell-to-Cell Interactions Between Tumor Cells and Mesenchymal Progenitors
por: Golinelli, Giulia, et al.
Publicado: (2022) -
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy
por: Rossignoli, Filippo, et al.
Publicado: (2018) -
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors
por: Golinelli, Giulia, et al.
Publicado: (2018) -
Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review
por: Mastrolia, Ilenia, et al.
Publicado: (2019) -
MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic Adenocarcinoma
por: Rossignoli, Filippo, et al.
Publicado: (2019)